lipantil supra 145 milligram film coated tablet
bgp products ltd - fenofibrate - film coated tablet - 145 milligram - fibrates - serum lipid reducing agents / cholesterol and triglycerides reducers / fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. mixed hyperlipidaemia when a statin is contraindicated or not tolerated. mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.
lipantil supra 215 milligram film coated tablet
bgp products ltd - fenofibrate - film coated tablet - 215 milligram - fibrates
lipantil supra 215 mg, film-coated tablet
mylan ire healthcare limited - fenofibrate - film-coated tablet - 215 milligram(s) - fibrates; fenofibrate
lipanthyl 145mg film-coated tablet
abbott products s.a.s - fenofibrate 145 mg - film-coated tablet
lipanthyl penta 145 film coated tablet
abbott laboratories (m) sdn. bhd. - fenofibrate -
lipantil supra 145 milligram coated tablets
abbott healthcare products ltd - fenofibrate - coated tablets - 145 milligram
lipanthyl supra 160 tablet 160 mg
abbott laboratories (singapore ) private limited - fenofibrate - tablet, film coated - 160 mg - fenofibrate 160 mg
lipanthylnano 145 mg film-coat. tabl.
viatris healthcare sa-nv - fenofibrate 145 mg - film-coated tablet - 145 mg - fenofibrate 145 mg - fenofibrate
lipanthyl 145mg f.c. tablets film-coated tablet
recipharma - fenofibrate - film-coated tablet - 145 mg
lipanthyl 145mg f.c. tablets film-coated tablet
abbott laboratories gmbh, germany - fenofibrate - film-coated tablet - 145 mg